Brief: aap Implantate 2016 sales and EBITDA below guidance

aap Implantate AG

21/03/2017 13:58

March 21 (Reuters) - aap Implantate AG  AAQG.DE : 
    * Sales by 514,000 euros ($555,993.80) and EBITDA by 450,000 euros slightly below guidance 
for financial year 2016 due to failure of distributor to fulfil contractual duties 
    * Announces that in course of drawing up annual financial statements for 2016 management 
board decided as a precautionary measure to revoke an initial sale with a distribution partner 
invoiced in financial year 
    * Reason is a delayed payment of contractual due purchase price 
    * In continued operation in financial year 2016 sales are at 10.5 million euros and EBITDA 
at -7.9 million euros and thereby slightly below current guidance 
 
Source text for Eikon:  ID:nEQ7P5w6F  
Further company coverage:  AAQG.DE  
 
($1 = 0.9245 euros) 
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))